For 17 years, Joseph Rubin's heart often skipped a beat. He has atrial fibrillation, a form of arrhythmia. Rubin, 51, loves to work out and has tried every available option to keep his heart beating ...
NEW ORLEANS (Reuters) - Sanofi-Aventis's experimental drug Multaq significantly reduced the incidence of hospitalization and length of hospital stays in patients with atrial fibrillation, according to ...
LONDON, March 30 (Reuters) - Sanofi-Aventis's heart drug Multaq has been recommended for limited use on Britain's state health service, after all, following a change of tack by the country's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results